October 31, 2018
Rose
The pharmaceutical giant signaled that prescription drug price increases could return in 2019 after postponing planned hikes in July. The news was made during Pfizer's third-quarter earnings call, in which the drugmaker also said its profits were up but that revenue did not hit forecasts. Bloomberg also reports on the company's hospital drug problems.
from Kaiser Health News https://ift.tt/2Pz05MV
October 31, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Viewpoints: Risk-Taking Lessons On Biohacking; In Commentary On Kate Spade’s Death You Hear Common Myths About Depression- Podcast: KHN’s ‘What The Health?’ Health Care Politics, Midterm Edition
- Kate Spade’s Death Ignites Concern About Rising Suicide Rate
- He Started Vaping As A Teen And Now Says Habit Is ‘Impossible To Let Go’
- Different Takes: When Good-Enough Medicaid Care Is Really Bad; Medicare Marches Closer To Fiscal Flop
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment